Evaluating the Efficacy of Modified BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country
Abstract: Background: High-dose chemotherapy followed by Autologous SCT (stem cell transplantation) is a treatment of choice for relapsed and refractory lymphoma. Due to cost, toxicity, and shortage of Carmustine, we decided to conduct a phase 2 clinical trial to evaluate the safety and efficacy...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Tehran University of Medical Sciences
2023-04-01
|
| Serie: | International Journal of Hematology-Oncology and Stem Cell Research |
| Soggetti: | |
| Accesso online: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1930 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|